Shopping Cart
Remove All
Your shopping cart is currently empty
PDGFRαkinase-IN-2 is a potent inhibitor of PDGFR-α with an IC50 of 2.1 nM. It exhibits anticancer activity against human colon cancer HT-29 cells, with an IC50 of 1.48 μM. Additionally, PDGFRαkinase-IN-2 demonstrates anti-angiogenic properties in zebrafish models with low embryotoxicity, making it suitable for research in colon cancer and anti-angiogenesis.


| Description | PDGFRαkinase-IN-2 is a potent inhibitor of PDGFR-α with an IC50 of 2.1 nM. It exhibits anticancer activity against human colon cancer HT-29 cells, with an IC50 of 1.48 μM. Additionally, PDGFRαkinase-IN-2 demonstrates anti-angiogenic properties in zebrafish models with low embryotoxicity, making it suitable for research in colon cancer and anti-angiogenesis. |
| Targets&IC50 | PDGFRα:2.1 nM |
| In vivo | PDGFRα kinase-IN-2 (Compound 6o) (0.1-10 μM, 72 h) significantly hinders the formation of zebrafish intersegmental vessels (ISV) in a dose-dependent manner and demonstrates superior anti-angiogenic activity compared to Sorafenib. Enpp-1-IN-27 (0.1-50 μM, 24 h) exhibits a particularly low lethality rate in zebrafish embryos and has a weaker effect than Sorafenib. |
| Molecular Weight | 429.47 |
| Formula | C24H23N5O3 |
| Cas No. | 3066103-58-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.